A method for preparing a pair of personalized three-dimensional (3D) printing medical isolation goggles includes the steps of S1: establishing a medical isolation goggles matrix; S2: acquiring the facial data of a user; S3: establishing a personalized medical isolation goggles model; S4: performing additive manufacturing, wherein a pair of medical isolation goggles is provided with high personalized fitness and high breathability for patients with eye diseases such as conjunctivitis, virus-susceptible patients, front-line clinical medical workers and related workers, and the compression damage to the face caused by the wearing of the medical isolation goggles for a long time is reduced in terms of fitness and comfort, where the medical isolation goggles are manufactured in a mode of additive manufacturing, small-batch rapid production can be performed after data merging, and a large number of processes and costs are reduced in the production cycle.

A stress urinary incontinence device is provided to limit or prevent leakage of urine in an individual. The device includes a body comprising an inner portion surrounded by an outer portion. The outer portion comprises biocompatible material and has a contact face opposing a guide face. The contact face is configured to occlude the urethral opening of the individual. A guide having an interior portion surrounded by an exterior portion projects from the guide face to aid in the application of the device onto the urethral meatus beneath the inner labia and above the vaginal opening of the individual. The device comprises materials that render it reusable.

A variety of medical and non-medical devices are exploited by users to address a wide range of conditions. However, in the vast majority of instances the device has a limited number of options with respect to its fit for the user and its performance. Further, the determination of target performance and fit are established on a qualitative basis rather than a quantitative basis. In many instances these combinations lead to low user acceptance of the device due to the resulting performance and fit issues. Accordingly, it would enhance performance and user acceptance if a quantitative determination provided a recommended type where options exist, and this determination provided the basis of a custom designed device to the user's specific anatomical and/or performance requirements.

A method of fabricating a casting, the method including applying a substrate to a sacrificial mold, the sacrificial mold including a shaped non-planar receiving surface to receive the substrate and provide a casting of the substrate having a shaped structure corresponding to the receiving surface; and subjecting the sacrificial mold and casting to freeze drying conditions and sublimating the sacrificial mold from the casting to form a cast article including the shaped non-planar structure.

A method of preparing a structure is provided. The method includes providing an initial structure; casting a first material in one or more void volumes of the initial structure; removing the initial structure from the first material; obtaining a cast structure comprising the first material; coating a second material on the cast structure; casting a third material using the coated cast structure; removing the first material; and obtaining a final structure. In various embodiments, the initial structure can include a first initial structure and a second initial structure and casting a first material in one or more first void volumes of the first initial structure and in one or more second void volumes of the second initial structure. In various embodiments, the method includes assembling the first cast structure and the second cast structure and obtaining an assembled structure comprising the first cast structure and the second cast structure.

In a method for producing an implant from a biocompatible silicone, a 3D mathematical model of an implant to be produced is used to create a 3D model of a casting mold for the implant as a negative. The casting mold is produced from a polymeric material through an additive manufacturing process and coated through vapor deposition of a coating material from the parylene family at least in a region that comes into contact with the biocompatible silicone to be cast. A platinum-catalyzed 2-component thermosetting silicone as the biocompatible silicone for the implant is introduced into a mold cavity of the coated casting mold, with a residence time of the implant in a patient's body of more than 29 days. The casting mold is heated to vulcanize the biocompatible silicone, and after cooling down the vulcanized implant is demolded from the casting mold.

A method of manufacturing a covered stent is disclosed. The method includes winding a first PTFE tape around a cylinder body of a jig, winding a second PTFE tape around a stent including the jig fitted therein, heating the stent in an oven, fitting the stent into upper and lower elastic members, fitting the elastic members into a mold, pressing the upper elastic member to bond the PTFE tapes to each other and to thus form a first film at a cylindrical body of the stent, taking the elastic members out of the mold, taking the stent out of the elastic members, removing the jig from the stent, forming a silicone coating layer at an expansion portion of the stent, and sewing the spaces in the expansion portion, the second PTFE tape, and the silicone coating layer to form a second film at the expansion portion.

Systems and methods for the manufacture of an hourglass shaped stent-graft assembly comprising an hourglass shaped stent, graft layers, and an assembly mandrel having an hourglass shaped mandrel portion. Hourglass shaped stent may have superelastic and self-expanding properties. Hourglass shaped stent may be encapsulated using hourglass shaped mandrel assembly coupled to a dilatation mandrel used for depositing graft layers upon hourglass shaped mandrel assembly. Hourglass shaped mandrel assembly may have removably coupled conical portions. The stent-graft assembly may be compressed and heated to form a monolithic layer of biocompatible material. Encapsulated hourglass shaped stents may be used to treat subjects suffering from heart failure by implanting the encapsulated stent securely in the atrial septum to allow blood flow from the left atrium to the right atrium when blood pressure in the left atrium exceeds that on the right atrium. The encapsulated stents may also be used to treat pulmonary hypertension.

Methods for producing a custom-made stapes prosthesis for a patient and stapes prostheses so produced. The methods may include obtaining a three-dimensional image of a natural stapes bone of the patient; and forming a stapes prosthesis that closely approximates a three-dimensional shape of the natural stapes bone via an additive manufacturing technique based on the three-dimensional image. The stapes prosthesis comprises a suitable material that is not osteogenic and is not cytotoxic. The stapes prosthesis may include a plurality of pores having an average size of from about 5 to about 100 micrometers and may exhibit a frequency of sound transmission in a range of from about 2 to about 30 kilohertz.

A medical support device (1), for use in a woman's breast as an implant without incapsulated material, wherein the medical support device (1) comprises at least a wall shaped portion (2) having a first side (3), which shows a bulge out of a plane (4), and a second side (5) of the wall shaped portion (2) has a corresponding cavity, for example a dome shape, wherein the medical support device (1) comprises an elastomer. The device will keep endogenous tissue and/or fat and/or added material, such as hyaluronic acid, in place inside of deep gland tissue of a woman's breast by means of being attached to tissue, such as muscle. A method of producing and to use such a medical support device (1).